Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPERIOR-1
CTR20255046Phase 2Active
- Sponsor
- Chengdu Auda Biotech
- Start
- Dec 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Exd391209 in obesity, Overweight, sponsored by Chengdu Auda Biotech. Started Dec 2025; status: active.
02
Drugs
Exd391209
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on CTR20255046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255046.